Virginia Retirement Systems’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
RCMNY
CP
Virginia Retirement Systems's ADMA Position: Q2 2026 in Review
Virginia Retirement Systems reduced its ADMA Biologics (ADMA) stake by 5% in Q2 2026, selling an estimated $42.8K and leaving 89,337 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #841.
Virginia Retirement Systems first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.77M in Q1 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- Virginia Retirement Systems held 89,337 shares of ADMA Biologics worth $748K as of Q2 2026.
- Virginia Retirement Systems sold 4,700 ADMA Biologics shares in Q2 2026, an estimated $42.8K.
- ADMA Biologics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #841 holding.
- Virginia Retirement Systems first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
- Virginia Retirement Systems's ADMA Biologics position peaked at $1.77M in Q1 2025.
- 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.